 <h1>Goserelin Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2>In Summary</h2><p><b>Commonly reported side effects of goserelin include:</b> headache, vasodilation, and diaphoresis. <b>Other side effects include:</b> hypertension.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to goserelin: subcutaneous implant</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, goserelin may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<i>Check with your doctor or nurse immediately</i> if any of the following side effects occur while taking goserelin:</p><p>
<i>For all adults</i>
</p><p>
<i>Less common</i>
</p><ul>
<li>Fast or irregular heartbeat</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Bone, muscle, or joint pain</li>
<li>changes in skin color of the face</li>
<li>fainting</li>
<li>fast or irregular breathing</li>
<li>numbness or tingling of the hands or feet</li>
<li>puffiness or swelling of the eyelids or around the eyes</li>
<li>skin rash, hives, or itching</li>
<li>sudden, severe decrease in blood pressure and collapse</li>
<li>tightness in the chest</li>
<li>troubled breathing</li>
</ul><p>
<i>For females only</i>
</p><p>
<i>Rare</i>
</p><ul>
<li>Anxiety</li>
<li>deepening of voice</li>
<li>increased hair growth</li>
<li>mental depression</li>
<li>mood changes</li>
</ul><p>
<i>For males only</i>
</p><p>
<i>Rare</i>
</p><ul>
<li>Pain in the chest</li>
<li>pain in the groin or legs (especially in the calves of the legs)</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of goserelin may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>For all adults</i>
</p><p>
<i>More common</i>
</p><ul>
<li>Sudden sweating and feelings of warmth (also called hot flashes)</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Blurred vision</li>
<li>burning, itching, redness, or swelling at the place of injection</li>
<li>decreased interest in sexual intercourse</li>
<li>dizziness</li>
<li>headache</li>
<li>nausea or vomiting</li>
<li>swelling and increased tenderness of the breasts</li>
<li>swelling of the feet or lower legs</li>
<li>trouble sleeping</li>
<li>weight gain</li>
</ul><p>
<i>For females only</i>
</p><p>
<i>More common</i>
</p><ul>
<li>Light, irregular vaginal bleeding</li>
<li>stopping of menstrual periods</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Burning, dryness, or itching of the vagina</li>
<li>pelvic pain</li>
</ul><p>
<i>For males only</i>
</p><p>
<i>Less common</i>
</p><ul>
<li>Bone pain</li>
<li>constipation</li>
<li>decreased size of the testicles</li>
<li>inability to have or keep an erection</li>
</ul><p>
<!-- end subcutaneous implant --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to goserelin: subcutaneous implant</i></p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Sexual dysfunction (21%), erectile dysfunction (18%), lower urinary tract symptoms (13%), vaginitis, breast atrophy, breast enlargement</p>
<p><b>Common</b> (1% to 10%): Gynecomastia, incontinence and urinary frequency (after radiotherapy), ureteric obstruction, pelvic pain</p>
<p><b>Uncommon</b> (0.1% to 1%): Breast tenderness<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Libido decreased, emotional lability</p>
<p><b>Common</b> (1% to 10%): Mood changes, depression, insomnia</p>
<p><b>Very rare</b> (less than 0.01%): Psychotic disorder<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Hyperhidrosis, acne, seborrhea</p>
<p><b>Common</b> (1% to 10%): Rash, pruritus</p>
<p><b>Frequency not reported</b>: Alopecia<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Hot flashes (62%)</p>
<p><b>Common</b> (1% to 10%): Cardiac failure, myocardial infarction, blood pressure abnormal</p>
<p><b>Frequency not reported</b>: QT prolongation</p>
<p><b>Postmarketing reports</b>: Deep vein thrombosis, stroke, transient ischemic attack<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache</p>
<p><b>Common</b> (1% to 10%): Paresthesia, spinal cord compression, dizziness</p>
<p><b>Postmarketing reports</b>: Convulsions<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Diarrhea (36%), cystitis (16%), rectal bleeding (14%)</p>
<p><b>Common</b> (1% to 10%): Proctitis, vomiting<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Pharyngitis</p>
<p><b>Common</b> (1% to 10%): Upper respiratory infection, chronic obstructive pulmonary disease<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Drug hypersensitivity </p>
<p><b>Rare</b> (0.01% to 0.1%): Anaphylactic reaction<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Bone pain, myalgia, leg cramps, hypertonia</p>
<p><b>Uncommon</b> (0.1% to 1%): Arthralgia</p>
<p><b>Postmarketing reports</b>: Osteoporosis, decreased bone mineral density and bone fracture in men<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Glucose tolerance impaired, weight increased, anorexia<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Hematuria<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Very rare</b> (less than 0.01%): Pituitary hemorrhage/infarction<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Very rare</b> (less than 0.01%): Pituitary tumor<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Influenza syndrome<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Injection site reaction</p><h3>Other</h3><p><b>Common</b> (1% to 10%): Lethargy, pain, edema<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Zoladex (goserelin)." Zeneca Pharmaceuticals, Wilmington, DE. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about goserelin</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Espa√±ol</li>
<li>68 Reviews</li>
<li>Drug class: gonadotropin releasing hormones</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Goserelin Subcutaneous &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Zoladex</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Bleeding Disorder</li>
<li>Breast Cancer, Palliative</li>
<li>Endometriosis</li>
<li>Prostate Cancer</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to goserelin: subcutaneous implant</i></p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Sexual dysfunction (21%), erectile dysfunction (18%), lower urinary tract symptoms (13%), vaginitis, breast atrophy, breast enlargement</p><p><b>Common</b> (1% to 10%): Gynecomastia, incontinence and urinary frequency (after radiotherapy), ureteric obstruction, pelvic pain</p><p><b>Uncommon</b> (0.1% to 1%): Breast tenderness<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Libido decreased, emotional lability</p><p><b>Common</b> (1% to 10%): Mood changes, depression, insomnia</p><p><b>Very rare</b> (less than 0.01%): Psychotic disorder<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Hyperhidrosis, acne, seborrhea</p><p><b>Common</b> (1% to 10%): Rash, pruritus</p><p><b>Frequency not reported</b>: Alopecia<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Hot flashes (62%)</p><p><b>Common</b> (1% to 10%): Cardiac failure, myocardial infarction, blood pressure abnormal</p><p><b>Frequency not reported</b>: QT prolongation</p><p><b>Postmarketing reports</b>: Deep vein thrombosis, stroke, transient ischemic attack<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache</p><p><b>Common</b> (1% to 10%): Paresthesia, spinal cord compression, dizziness</p><p><b>Postmarketing reports</b>: Convulsions<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Diarrhea (36%), cystitis (16%), rectal bleeding (14%)</p><p><b>Common</b> (1% to 10%): Proctitis, vomiting<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Pharyngitis</p><p><b>Common</b> (1% to 10%): Upper respiratory infection, chronic obstructive pulmonary disease<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Drug hypersensitivity </p><p><b>Rare</b> (0.01% to 0.1%): Anaphylactic reaction<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Bone pain, myalgia, leg cramps, hypertonia</p><p><b>Uncommon</b> (0.1% to 1%): Arthralgia</p><p><b>Postmarketing reports</b>: Osteoporosis, decreased bone mineral density and bone fracture in men<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Glucose tolerance impaired, weight increased, anorexia<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Hematuria<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Very rare</b> (less than 0.01%): Pituitary hemorrhage/infarction<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Very rare</b> (less than 0.01%): Pituitary tumor<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Influenza syndrome<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Injection site reaction</p><h3>Other</h3><p><b>Common</b> (1% to 10%): Lethargy, pain, edema<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Zoladex (goserelin)." Zeneca Pharmaceuticals, Wilmington, DE. </p><h2>More about goserelin</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Espa√±ol</li>
<li>68 Reviews</li>
<li>Drug class: gonadotropin releasing hormones</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Goserelin Subcutaneous &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Bleeding Disorder</li>
<li>Breast Cancer, Palliative</li>
<li>Endometriosis</li>
<li>Prostate Cancer</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>